In Consulting Services

PharmaNet offers a comprehensive range of early- and late-phase consulting services on topics including: international regulatory affairs; scientific and medical affairs; quality; risk management; chemistry, manufacturing and controls; as well as biopharmaceutical investor issues.

Regulatory Liaison

The ideal person to serve as liaison between your internal regulatory affairs department and a regulatory agency is someone who has experience on both sides of the table. PharmaNet Consulting offers the services of former senior-level FDA officials from all three FDA human therapeutic centers: Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation and Research (CBER), and Center for Devices and Radiological Health (CDRH). In addition, PharmaNet professionals offer experience with the Canadian HPFB, European MHRA, as well as other international agencies. PharmaNet professionals can assist you with meetings, briefing documents, warning letters, and hearings.

 

PharmaNet professionals available for consultation on this topic include:

 

Andrew Chang, PhD

Executive Director, PharmaNet Consulting

 

Bengt Danielsson, MD, PhD

Vice President, PharmaNet Consulting


William M. Egan, PhD

Vice President, PharmaNet Consulting


Joyce Lea Frey-Vasconcells, PhD

Executive Director, PharmaNet Consulting

 

Gregory M. Hockel, MBA, PhD

Senior Vice President, Regulatory Affairs Worldwide

 

Mario Tanguay, BPharm, PhD

Vice President, Scientific and Regulatory Affairs, Anapharm


Fethi Trabelsi, PhD

Director, Scientific and Regulatory Affairs, Anapharm

 

Duu-Gong Wu, PhD

Executive Director, PharmaNet Consulting

 

PharmaNet Development Group, Inc.504 Carnegie Center, Princeton, NJ 08540Tel 609 951 6800Fax 609 514 0390